Litigation for eribulin mesylate
✉ Email this page to a colleague
US Court Litigation for eribulin mesylate
| Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
|---|---|---|---|---|---|---|---|---|
| 6,214,865 | ⤷ Start Trial | 2:22-cv-05950|D.N.J. | 2022-10-07 | 2023-11-07 | 35:271 Patent Infringement | District Court, D. New Jersey | ⤷ Start Trial | |
| 6,214,865 | ⤷ Start Trial | 2:22-cv-05950-SRC-JRA|D.N.J. | 2022-10-07 | 35:271 Patent Infringement | District Court, D. New Jersey | ⤷ Start Trial | ||
| RE46,965 | Eisai R&D Management Co., Ltd v. Long Grove Pharmaceuticals, LLC | 1:22-cv-01211|D. Del. | 2022-09-15 | 2023-01-18 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Start Trial |
| >Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
